TransMedics Group, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.69M, a 31.26% increase year-over-year.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $1.96M, a 37.95% increase year-over-year.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $1.29M, a 101.57% increase year-over-year.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $1.42M, a 149.21% increase year-over-year.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $3.25M, a 57.64% increase from fiscal 2024.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.06M, a 115.81% increase from fiscal 2023.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $955.00K, a 87.62% increase from fiscal 2022.
- TransMedics Group, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $509.00K, a 21.48% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.69M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $3.25M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $1.96M 10-Q · filed 2025-10-29 | |
| 2025-03-31 | $1.29M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $2.06M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.42M 10-Q · filed 2025-10-29 | |
| 2024-03-31 | $638.00K 10-Q · filed 2025-10-29 | |
| 2023-12-31 | $955.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | $571.00K 10-Q · filed 2024-10-29 | |
| 2023-03-31 | $384.00K 10-Q · filed 2024-10-29 | |
| 2022-12-31 | $509.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $306.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $203.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $419.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $208.00K 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $211.00K 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $357.00K 10-K · filed 2023-02-27 | |
| 2020-09-30 | $160.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $197.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |